Alexander Schmittel - Concepedia

Author

Alexander Schmittel

Also Known As

A SCHMITTEL, A Schmittel, A. H. Schmittel, A. SCHMITTEL, A. Schmittel, Alexander H. Schmittel, Alexander Schmittel, Alexander Schmittel,, Schmittel, A., Schmittel, Alexander

179

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Franklin University Freie Universität Berlin Heidelberg University University Hospital Heidelberg

About

Alexander Schmittel is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	32	2.5K
2	Health Sciences	4	4	388
3	Cell Biology	4	4	217
4	Public Health	3	3	248
5	Allergy	2	2	262

Alexander Schmittel

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial M. M. Heiss, P. Murawa, P. Koralewski, International Journal of Cancer Tumor BiologyMedicinePuncture-free SurvivalImmunologyPathology	2010	547
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia Carmen Scheibenbogen, Anne Letsch, Eckhard Thiel, Blood	2002	250
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients Zhian Liu, Alberto Fusi, Eva Klopocki, Journal of Translational Medicine	2011	184
Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group Ulrich Keilholz, Cornelis J.A. Punt, Martin Gore, Journal of Clinical Oncology	2005	166
Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer G. Goeckenjan, H. Sitter, Michael Thomas, Pneumologie Advanced Lung DiseaseInterdisciplinary GuidelineClinical SpecialtiesClinical GuidelinesOncology	2010	150
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Dirk Nagorsen, Ulrich Keilholz, Licia Rivoltini, PubMed Healthy SubjectsMhc ClassT-regulatory CellImmunologyCrc Patients	2000	137
Evaluation of the interferon-γ ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood Alexander Schmittel, Ulrich Keilholz, Carmen Scheibenbogen Journal of Immunological Methods AllergyPeptide Specific TLaboratory ImmunologyImmunodeficienciesImmune Regulation	1997	132
Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trial Carmen Scheibenbogen, Pedro Romero, Licia Rivoltini, Journal of Immunological Methods Clinical ImmunologyImmunohematologyChromium-release AssayAllergyLaboratory Immunology	2000	130
Phase 2 Trial of Vaccination With Tyrosinase Peptides and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma Carmen Scheibenbogen, Alexander Schmittel, Ulrich Keilholz, Journal of Immunotherapy	2000	130
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma Kristoph Jahnke, Agnieszka Korfel, Peter Martus, Annals of Oncology	2005	113

Page 1